Published 2020 | Version v1
Miscellaneous

Nanomedicine for MRT: what's past is prologue

  • 1. Illawarra Health and Medical Research Institute, University of Wollongong, North Wollongong, NSW (Australia)
  • 2. Centre for Medical Radiation Physics, University of Wollongong, North Wollongong, NSW (Australia)
  • 3. Radiation Oncology Medical Physics, Prince of Wales Hospital, Randwick, NSW (Australia)

Description

Synchrotron microbeam radiation therapy (MRT) is a novel technique that uses a spatially fractionated field to induce cancer selectivity in treatment. Complemented with high-Z nanoparticles, MRT treatment of cancer becomes even more targeted and sparing of healthy tissue. For the first time, this study determines the factors that affect synchrotron microbeam activation therapy (SMART) using thulium nanoparticles (TmNPs). (author)

Part of:
Mini- Micro- Nano Dosimetry and Innovative Technologies in Radiation Oncology, 2020. Program and Abstracts

Additional details

Identifiers

Publishing Information

Imprint Title
Mini- Micro- Nano Dosimetry and Innovative Technologies in Radiation Oncology, 2020. Program and Abstracts
Imprint Pagination
138 p.
Journal Page Range
p. 64
Report number
INIS-AU--0096

Conference

Title
Mini- Micro- Nano Dosimetry and Innovative Technologies in Radiation Oncology Conference
Acronym
MMND-ITRO 2020
Dates
10-16 Feb 2020
Place
North Wollongong, NSW (Australia)

Optional Information

Notes
1 fig., 1 ref Imprint:Welcome address by co-chairs Professor Anatoly Rozenfeld (Centre for Medical Radiation Physics (AU) and Dr. Yoshiya (Josh) Yamada (Memorial Sloan Kettering Cancer Centre (MSKCC) (US)